BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2296275)

  • 1. Assessing the risk of recurrence in breast cancer.
    Ingle JN
    N Engl J Med; 1990 Feb; 322(5):329-31. PubMed ID: 2296275
    [No Abstract]   [Full Text] [Related]  

  • 2. Cathepsin D and prognosis in breast cancer.
    Tandon AK; Clark GM; Chamness GC; Chirgwin JM; McGuire WL
    N Engl J Med; 1990 Feb; 322(5):297-302. PubMed ID: 2296271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
    Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
    Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytosol cathepsin D in Thai women with breast cancer.
    Chearskul S; Bhothisuwan K; Tunsuphasiri V; Churinthrapun M; Keyanond V; Ornrheabroi S
    J Med Assoc Thai; 1996 Oct; 79(10):654-60. PubMed ID: 8997001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin D may help in discriminating node-negative breast cancer patients at risk for local-regional recurrence.
    Ardavanis A; Scorilas A; Loukeri A; Gerakini F; Pissakas G; Missitzis I; Apostolikas N; Yiotis I
    Anticancer Res; 1998; 18(4B):2885-90. PubMed ID: 9713481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cathepsin D in diagnosis of neoplastic diseases].
    Warwas M; Taurowska E
    Postepy Hig Med Dosw; 1993; 47(4):277-88. PubMed ID: 8309853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cathepsin D as a prognostic marker in breast cancer].
    Asculai E; Gopas J; Cohen Y
    Harefuah; 1996 Jun; 130(11):787-90. PubMed ID: 8794687
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.
    Thorpe SM; Rochefort H; Garcia M; Freiss G; Christensen IJ; Khalaf S; Paolucci F; Pau B; Rasmussen BB; Rose C
    Cancer Res; 1989 Nov; 49(21):6008-14. PubMed ID: 2790815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin D test helps identify breast cancers likely to recur.
    Oncology (Williston Park); 1990 Mar; 4(3):109. PubMed ID: 2144440
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cathepsin D expression in primary breast cancer. Comparison of immunohistochemical and biochemical results].
    Göhring UJ; Ingenhorst A; Crombach G; Scharl A
    Pathologe; 1993 Dec; 14(6):313-7. PubMed ID: 8121884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cathepsin D in primary breast cancer in correlation with various prognostic factors].
    Rempen A; Caffier H
    Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):272-5. PubMed ID: 1650323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor markers in diagnosis of breast cancer].
    Bartel U
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):1015-21. PubMed ID: 1776283
    [No Abstract]   [Full Text] [Related]  

  • 13. Salivary markers: their role in breast cancer detection.
    Chase WR
    J Mich Dent Assoc; 2000 Feb; 82(2):12. PubMed ID: 11323899
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and biological differences between tetraploid and hypertetraploid infiltrating ductal carcinomas of the breast. Preliminary study].
    Ruibal A; del Río MC; Arias J; Schneider J; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):247-8. PubMed ID: 11062091
    [No Abstract]   [Full Text] [Related]  

  • 15. Human breast cancer: prognostic significance of DNA ploidy compared with c-erbB2 expression, Cathepsin D and silver-binding nucleolar organizer regions (AgNORs).
    Borgiani L; Cogorno P; Buccaran G; Gallo L; Rovida S; Canepa M
    Pathologica; 1994 Aug; 86(4):350-5. PubMed ID: 7708434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prognostic value of cathepsin D concentration in cytosol of primary breast carcinoma].
    Bussen S; Rempen A; Caffier H
    Zentralbl Gynakol; 1995; 117(5):253-9. PubMed ID: 7793167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays.
    Kute TE; Shao ZM; Sugg NK; Long RT; Russell GB; Case LD
    Cancer Res; 1992 Oct; 52(19):5198-203. PubMed ID: 1394123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma of the vulva. Expression of tumor proteases cathepsin-D and pro-cathepsin-L.
    Hantschmann P; Beysiegel S; Kurzl R
    J Reprod Med; 1998 Nov; 43(11):933-42. PubMed ID: 9839260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular prognostic factors for breast cancer metastasis and survival.
    Esteva FJ; Sahin AA; Cristofanilli M; Arun B; Hortobagyi GN
    Semin Radiat Oncol; 2002 Oct; 12(4):319-28. PubMed ID: 12382190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors in breast cancer patients].
    Roisman I; Peretz T; Reznick AZ; Lifshitz I; Bitterman A; Fares F; Toledano H; Barzilay A; Durst AL
    Harefuah; 1996 May; 130(10):693-9. PubMed ID: 8794662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.